SCHEMBL3426089

SCHEMBL3426089

O=C1NCCC(=NNc2ccc(Cl)cn2)c2c1[nH]c1ccc(F)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 6/20 1.00
CDK5R1 Q15078 6/20 1.00
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
GSK3A P49840 2/20 0.35
GSK3B P49841 2/20 0.35
IDO1 P14902 2/20 0.35
TDO2 P48775 1/20 0.35
ALDH1A1 P00352 3/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LMNA P02545 2/20 0.34
IDH1 O75874 2/20 0.34
MAPT P10636 3/20 0.34
POLB P06746 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3426086 1.00 CDK5 (1.00) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL13341199 1.00 CDK5 (1.00) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL3426489 0.92 CDK5 (0.86) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL3426485 0.92 CDK5 (0.86) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL13341173 0.92 CDK5 (0.86) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL3426044 0.87 CDK5 (0.77) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL13341183 0.87 CDK5 (0.77) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL3426040 0.87 CDK5 (0.77) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL3426279 0.86 CDK5 (0.75) CDK5CDK5R1NPC1RAB9AGSK3A
SCHEMBL3426282 0.86 CDK5 (0.75) CDK5CDK5R1NPC1RAB9AGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137555-A1 Compounds and Compositions as Protein Kinase Inhibitors IRM LLC (BM) 2009-05-28 US claimed
US-20050153955-A1 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2005-07-14 US claimed
WO-2004098520-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2004-11-18 WO claimed
US-7713958-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2010-05-11 US disclosed
US-20090137555-A1 Compounds and Compositions as Protein Kinase Inhibitors IRM LLC (BM) 2009-05-28 US disclosed
US-7423031-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2008-09-09 US disclosed
US-20050153955-A1 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2005-07-14 US disclosed
WO-2004098520-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153955-A1 Compounds and compositions as protein kinase inhibitors CDK1, CDK3, CDK11A CDK5 16/4885CDK5R1 38/4885NPC1 2859/4885
US-20090137555-A1 Compounds and Compositions as Protein Kinase Inhibitors CDK1, CDK3, CDK2 CDK5 14/4885CDK5R1 37/4885NPC1 3159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.